MGI/SuperGen’s Dacogen On Deck For Late May Launch
The myelodysplastic syndromes therapy could post $25 mil. in 2006 sales, MGI said following the May 3 approval.
The myelodysplastic syndromes therapy could post $25 mil. in 2006 sales, MGI said following the May 3 approval.